These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 9776715)
1. Reactive oxygen species modified polyguanylic acid: immunogenicity and implications for systemic autoimmunity. Garg DK; Ali R J Autoimmun; 1998 Aug; 11(4):371-8. PubMed ID: 9776715 [TBL] [Abstract][Full Text] [Related]
2. Hydroxyl radical modification of polyguanylic acid: role of modified guanine in circulating SLE anti-DNA autoantibodies. Garg DK; Moinuddin ; Ali R Immunol Invest; 2003 Aug; 32(3):187-99. PubMed ID: 12916708 [TBL] [Abstract][Full Text] [Related]
3. Binding of SLE autoantibodies to native poly(I), ROS-poly(I) and native DNA: a comparative study. Tasneem S; Ali R J Autoimmun; 2001 Nov; 17(3):199-205. PubMed ID: 11712857 [TBL] [Abstract][Full Text] [Related]
4. Immunogenicity of singlet oxygen modified human DNA: implications for anti-DNA antibodies in systemic lupus erythematosus. Al Arfaj AS; Chowdhary AR; Khalil N; Ali R Clin Immunol; 2007 Jul; 124(1):83-9. PubMed ID: 17540620 [TBL] [Abstract][Full Text] [Related]
5. Binding of circulating SLE autoantibodies to oxygen free radical damaged chromatin. Mansoor F; Ali A; Ali R Autoimmunity; 2005 Sep; 38(6):431-8. PubMed ID: 16278148 [TBL] [Abstract][Full Text] [Related]
6. Immunogenicity of mitochondrial DNA modified by hydroxyl radical. Alam K; Moinuddin ; Jabeen S Cell Immunol; 2007 May; 247(1):12-7. PubMed ID: 17716639 [TBL] [Abstract][Full Text] [Related]
7. Hydroxyl radical modification of human serum albumin generated cross reactive antibodies. Rasheed Z; Khan MW; Ali R Autoimmunity; 2006 Sep; 39(6):479-88. PubMed ID: 17060027 [TBL] [Abstract][Full Text] [Related]
8. Zinc is an essential cofactor for recognition of the DNA binding domain of poly(ADP-ribose) polymerase by antibodies in autoimmune rheumatic and bowel diseases. Decker P; Briand JP; de Murcia G; Pero RW; Isenberg DA; Muller S Arthritis Rheum; 1998 May; 41(5):918-26. PubMed ID: 9588745 [TBL] [Abstract][Full Text] [Related]
9. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis. Russo K; Hoch S; Dima C; Varga J; Teodorescu M J Rheumatol; 2000 Jan; 27(1):142-8. PubMed ID: 10648030 [TBL] [Abstract][Full Text] [Related]
10. Binding characteristics of SLE anti-DNA autoantibodies to Catecholestrogen-modified DNA. Khan WA Scand J Immunol; 2006 Dec; 64(6):677-83. PubMed ID: 17083625 [TBL] [Abstract][Full Text] [Related]
11. Reactive oxygen species damaged human serum albumin in patients with type 1 diabetes mellitus: biochemical and immunological studies. Rasheed Z; Ali R Life Sci; 2006 Nov; 79(24):2320-8. PubMed ID: 16945391 [TBL] [Abstract][Full Text] [Related]
12. High prevalence of autoantibodies against the nuclear high mobility group (HMG) protein SSRP1 in sera from patients with systemic lupus erythematosus, but not other rheumatic diseases. Santoro P; De Andrea M; Migliaretti G; Trapani C; Landolfo S; Gariglio M J Rheumatol; 2002 Jan; 29(1):90-3. PubMed ID: 11824977 [TBL] [Abstract][Full Text] [Related]
13. Enhanced recognition of hydroxyl radical modified plasmid DNA by circulating cancer antibodies. Khan F; Ali A; Ali R J Exp Clin Cancer Res; 2005 Jun; 24(2):289-96. PubMed ID: 16110763 [TBL] [Abstract][Full Text] [Related]
14. Autoantibodies to lipoprotein lipase and dyslipidemia in systemic lupus erythematosus. Reichlin M; Fesmire J; Quintero-Del-Rio AI; Wolfson-Reichlin M Arthritis Rheum; 2002 Nov; 46(11):2957-63. PubMed ID: 12428237 [TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of superoxide radical modified-DNA: studies on induced antibodies and SLE anti-DNA autoantibodies. Waris G; Alam K Life Sci; 2004 Oct; 75(22):2633-42. PubMed ID: 15369699 [TBL] [Abstract][Full Text] [Related]
16. Enhanced recognition of reactive oxygen species damaged human serum albumin by circulating systemic lupus erythematosus autoantibodies. Rasheed Z; Ahmad R; Rasheed N; Ali R Autoimmunity; 2007 Nov; 40(7):512-20. PubMed ID: 17966041 [TBL] [Abstract][Full Text] [Related]
17. Measurement and significance of 3-nitrotyrosine in systemic lupus erythematosus. Khan F; Siddiqui AA; Ali R Scand J Immunol; 2006 Nov; 64(5):507-14. PubMed ID: 17032243 [TBL] [Abstract][Full Text] [Related]
18. Autoantibodies to the translational suppressors T cell intracytoplasmic antigen 1 and T cell intracytoplasmic antigen 1-related protein in patients with rheumatic diseases: increased prevalence in systemic lupus erythematosus and systemic sclerosis and correlation with clinical features. Jimenez-Boj E; Kedersha N; Tohidast-Akrad M; Karlhofer FM; Stummvoll G; Zimmermann C; Ulrich W; Guiducci S; Hoefler E; Aringer M; Schett G; Matucci-Cerinic M; Smolen JS; Steiner G Arthritis Rheum; 2008 May; 58(5):1226-36. PubMed ID: 18438838 [TBL] [Abstract][Full Text] [Related]
19. Cross-reactivity between anti-cardiolipin, anti-high-density lipoprotein and anti-apolipoprotein A-I IgG antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome. Delgado Alves J; Kumar S; Isenberg DA Rheumatology (Oxford); 2003 Jul; 42(7):893-9. PubMed ID: 12730551 [TBL] [Abstract][Full Text] [Related]
20. Cross-reactivity of antiidiotypic antibodies with DNA in systemic lupus erythematosus. Eivazova ER; McDonnell JM; Sutton BJ; Staines NA Arthritis Rheum; 2000 Feb; 43(2):429-39. PubMed ID: 10693885 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]